Literature DB >> 2168424

Expression of human parathyroid hormone-(1-84) in Escherichia coli as a factor X-cleavable fusion protein.

T J Gardella1, D Rubin, A B Abou-Samra, H T Keutmann, J T Potts, H M Kronenberg, S R Nussbaum.   

Abstract

Recombinant human parathyroid hormone (hPTH)-(1-84) was obtained from Escherichia coli using a cleavable fusion protein strategy. The fusion protein contains residues 1-138 of human growth hormone as the amino-terminal region and residues 1-84 of hPTH as the carboxyl-terminal region. A 7-residue linker containing the recognition/cleavage sequence of the site-specific blood coagulation protease activated factor X (factor Xa) joins the two regions. Intact hPTH-(1-84) is released from this fusion protein by cleavage in vitro with factor Xa. The fusion protein was produced at a high level and formed inclusion bodies which allowed it to be easily purified by low speed centrifugation, with a yield of approximately 50 mg/liter of culture. After factor Xa cleavage and high performance liquid chromatography purification, highly purified hPTH was obtained, with a final yield of 1.5-3 mg/liter. Physical and biological characterization of the purified hormone demonstrated that it was intact and active hPTH-(1-84).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168424

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Pharmacodynamic Actions of a Long-Acting PTH Analog (LA-PTH) in Thyroparathyroidectomized (TPTX) Rats and Normal Monkeys.

Authors:  Masaru Shimizu; Eri Joyashiki; Hiroshi Noda; Tomoyuki Watanabe; Makoto Okazaki; Miho Nagayasu; Kenji Adachi; Tatsuya Tamura; John T Potts; Thomas J Gardella; Yoshiki Kawabe
Journal:  J Bone Miner Res       Date:  2016-05-23       Impact factor: 6.741

2.  Oxidation of recombinant human parathyroid hormone: effect of oxidized position on the biological activity.

Authors:  Y Nabuchi; E Fujiwara; K Ueno; H Kuboniwa; Y Asoh; H Ushio
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

3.  Recombinant production of TEV cleaved human parathyroid hormone.

Authors:  Christopher O Audu; Jared C Cochran; Maria Pellegrini; Dale F Mierke
Journal:  J Pept Sci       Date:  2013-06-23       Impact factor: 1.905

4.  The stability and degradation pathway of recombinant human parathyroid hormone: deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues.

Authors:  Y Nabuchi; E Fujiwara; H Kuboniwa; Y Asoh; H Ushio
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

5.  Functional Properties of Two Distinct PTH1R Mutants Associated With Either Skeletal Defects or Pseudohypoparathyroidism.

Authors:  Ignacio Portales-Castillo; Thomas Dean; Ashok Khatri; Harald Jüppner; Thomas J Gardella
Journal:  JBMR Plus       Date:  2022-04-14

Review 6.  Strategies for achieving high-level expression of genes in Escherichia coli.

Authors:  S C Makrides
Journal:  Microbiol Rev       Date:  1996-09

7.  An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on des(1-3)insulin-like growth factor I.

Authors:  G Forsberg; B Baastrup; H Rondahl; E Holmgren; G Pohl; M Hartmanis; M Lake
Journal:  J Protein Chem       Date:  1992-04

8.  Phosphorylation of recombinant human phenylalanine hydroxylase: effect on catalytic activity, substrate activation and protection against non-specific cleavage of the fusion protein by restriction protease.

Authors:  A P Døskeland; A Martinez; P M Knappskog; T Flatmark
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

9.  Overexpression of Recombinant Human Teriparatide, rhPTH (1-34) in Escherichia coli : An Innovative Gene Fusion Approach.

Authors:  Nahid Bakhtiari; Zahra Amini Bayat; Sepideh Sagharidouz; Mohsen Vaez
Journal:  Avicenna J Med Biotechnol       Date:  2017 Jan-Mar

10.  A Novel Approach for High Level Expression of Soluble Recombinant Human Parathyroid Hormone (rhPTH 1-34) in Escherichia coli.

Authors:  Haleh Hamedifar; Firoozeh Salamat; Mohammad Saffarion; Mohammad Ghiasi; Alireza Hosseini; Hadi Lahiji; Zomorrod Nouri; Hamed Arfae; Fereidoun Mahboudi
Journal:  Avicenna J Med Biotechnol       Date:  2013-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.